Click here to view a replay of the "Drugs of Abuse: Qualitative Testing - What has the industry learned?" Webinar! This presentation will cover understanding the laboratory issues noted by the OIG. Attendees will learn which qualitative drug testing is at risk and what steps to take to mitigate the risk by:
- Understand coding guidelines of government and commercial payers for Qualitative Drug Testing
- Interpret and comply with the medical necessity and documentation guidelines of regional Medicare payers as defined by Local Coverage Determinations
- Determine substantial compliance of OIG for medication monitoring and drugs of abuse testing
* Note - Webinar Replays are NOT eligible for CEUs.